EX-10.45 9 dex1045.htm NON-EXCLUSIVE LICENSE AGREEMENT BETWEEN SEATTLE GENETICS, INC. AND ICOS CORP. NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • May 5th, 2020 • Washington
Contract Type FiledMay 5th, 2020 JurisdictionThis Non-exclusive License Agreement (the “Agreement”), effective as of October 16th, 2000 (The “Effective Date”), is entered into by and between ICOS Corporation, a Delaware corporation having offices at 22021 20th Avenue SE, Bothell, WA 98021, U.S.A., (“ICOS”), and Seattle Genetics, Inc., a Delaware corporation having offices at 22215 26th Avenue S.E., Suite 300, Bothell, WA 98021 (“LICENSEE”). All references to LICENSEE in this Agreement shall include its Affiliates (as such term is defined below).
NON-EXCLUSIVE LICENSE AGREEMENTNon-Exclusive License Agreement • November 26th, 2010 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • Washington
Contract Type FiledNovember 26th, 2010 Company Industry JurisdictionThis Non-exclusive License Agreement (the “Agreement”), effective as of October 16th, 2000 (The “Effective Date”), is entered into by and between ICOS Corporation, a Delaware corporation having offices at 22021 20th Avenue SE, Bothell, WA 98021, U.S.A., (“ICOS”), and Seattle Genetics, Inc., a Delaware corporation having offices at 22215 26th Avenue S.E., Suite 300, Bothell, WA 98021 (“LICENSEE”). All references to LICENSEE in this Agreement shall include its Affiliates (as such term is defined below).